Difference between revisions of "Androgen receptor"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 46: | Line 46: | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:23, 10 March 2015
| Androgen receptor | |
|---|---|
| Substrate peptide name | Androgen receptor |
| Synonyms | Dihydrotestosterone receptor |
| Determination type | In vitro |
| Source | Mus musculus |
| Subcellular localization | Nucleus |
| Swissprot ID | P19091 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | K311 |
| Substrate sequence | |
| Structure | 1GS4 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:12812978 |
| Notes | The N-terminal fragment was shown to be transglutaminase substrate, the substrate
Gln is situated probably in a polyQ containing region between residues 299-315 |
